How do I read and understand my Glioblastoma pathology report

GlioblastomaMay 19, 2026Navis AI

For informational purposes only

This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.

Understanding Your Glioblastoma Pathology Report

I'd be happy to help you understand your pathology report! This is an important document that describes what the pathologist found when examining your tumor tissue under the microscope.

What a Pathology Report Contains

A glioblastoma pathology report typically includes several key sections:

1. Tumor Grade and Classification

Your report should state that this is a Grade 4 glioma (the highest grade). Glioblastoma is the most aggressive type of brain tumor. The pathologist assigns this grade based on how abnormal the cells look and how quickly they're likely to grow.

2. Histological Findings (What the cells look like)

The pathologist describes:

Cell appearance: How abnormal the tumor cells are compared to normal brain cells
Mitotic activity: How many cells are actively dividing (higher numbers = faster growth)
Necrosis: Areas of dead cells within the tumor (common in glioblastoma)
Vascular proliferation: Abnormal blood vessel growth (typical in aggressive tumors)

3. Molecular/Genetic Testing (Very Important)

Modern pathology reports include testing for specific genetic markers that guide treatment:

IDH1/IDH2 mutation status: Whether the tumor has mutations in these genes
- IDH-wildtype (no mutation) = typical glioblastoma
- IDH-mutant = different subtype with potentially different prognosis
MGMT methylation status: This is crucial for treatment planning
- Methylated = tumor may respond better to certain chemotherapy
- Unmethylated = different treatment approach may be needed
TP53 status: Another genetic marker that provides prognostic information
EGFR amplification: Presence of extra copies of this gene

4. Specimen Information

Type of tissue sample (biopsy, surgical resection)
Size and location of the tumor
Margins (whether tumor was completely removed, if applicable)

Questions to Ask Your Oncologist

Since pathology reports can be complex, here are specific questions to discuss with your care team:

"What is my tumor's IDH and MGMT status, and what do these results mean for my treatment options?"
"Was the tumor completely removed, or is there residual disease remaining?"
"Based on my pathology findings, what is the recommended treatment plan (surgery, radiation, chemotherapy)?"
"Are there any clinical trials available for my specific tumor characteristics?"
"What do the molecular markers tell us about how my tumor might respond to treatment?"

Key Context: Why This Matters

According to NCCN (National Comprehensive Cancer Network) Guidelines for Central Nervous System Cancers, the molecular characteristics of your glioblastoma—particularly IDH and MGMT status—are essential for determining the most appropriate treatment approach. These markers help your oncologist predict how your tumor will behave and which therapies are most likely to be effective.